Home » Topics » BioWorld Science

BioWorld Science
RSS

CBT Pharmaceuticals obtains ethics approval in Australia for APOLLO-1 study

Aug. 9, 2018

Ambys and Takeda to pioneer first-in-class therapies for the treatment of serious liver diseases

Aug. 9, 2018

Positive topline data presented from the pivotal phase III SONICS study of Recorlev

Aug. 9, 2018

Identification of genetic prognosticators in glioblastoma survivors by NGS

Aug. 9, 2018

FDA approves Poteligeo for two subtypes of cutaneous T-cell lymphoma

Aug. 9, 2018

Positive data announced from phase II extension study of MVA-BN RSV universal vaccine

Aug. 9, 2018

Description of a phase I study evaluating locoregional immunotherapy for ovarian cancer recurrence

Aug. 9, 2018

Medshine Discovery synthesizes WEE1hu inhibitors

Aug. 9, 2018

Researchers present new NR1I2 agonists

Aug. 9, 2018

Bayer patents MKNK1 inhibitors

Aug. 9, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...